BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Gemzar gemcitabine: Phase III data

Researchers at the Intergroupe Francophone de Cancerologie Thoracique and colleagues reported data from the open-label, French Phase III IFCT-0501 trial in 451 patients ages 70-89 with locally advanced or metastatic NSCLC showing that platinum-based doublet chemotherapy with...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >